Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher...

por Furtado, Jeremy D., Ruotolo, Giacomo, Nicholls, Stephen J., Dullea, Robert, Carvajal-Gonzalez, Santos, Sacks, Frank M.
Publicado 2021

Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults

por Suico, Jeffrey G, Wang, Ming-Dauh, Friedrich, Stuart, Cannady, Ellen A, Konkoy, Christopher S, Ruotolo, Giacomo, Krueger, Kathryn A
Publicado 2014

Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals

por Piemonti, Lorenzo, Calori, Giliola, Lattuada, Guido, Mercalli, Alessia, Ragogna, Francesca, Garancini, Maria Paola, Ruotolo, Giacomo, Luzi, Livio, Perseghin, Gianluca
Publicado 2009

Diagnostic sensitivity of thyroid autoantibodies assessed in a population-based, cross-sectional study in adults

por Bosi, Emanuele, Bianchi, Roberto, Ruotolo, Giacomo, Bazzigaluppi, Elena, Belloni, Cristina, Calori, Giliola, Girardi, Anna Maria, Garancini, Maria Paola, Scavini, Marina
Publicado 2010

The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and...

por Wilson, Jonathan M., Nikooienejad, Amir, Robins, Deborah A., Roell, William C., Riesmeyer, Jeffrey S., Haupt, Axel, Duffin, Kevin L., Taskinen, Marja‐Riitta, Ruotolo, Giacomo
Publicado 2020

Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals: The Cremona Study

por Calori, Giliola, Lattuada, Guido, Piemonti, Lorenzo, Garancini, Maria Paola, Ragogna, Francesca, Villa, Marco, Mannino, Salvatore, Crosignani, Paolo, Bosi, Emanuele, Luzi, Livio, Ruotolo, Giacomo, Perseghin, Gianluca
Publicado 2011

The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabe...

por Wilson, Jonathan M., Lin, Yanzhu, Luo, M. Jane, Considine, Gary, Cox, Amy L., Bowsman, Lenden M., Robins, Deborah A., Haupt, Axel, Duffin, Kevin L., Ruotolo, Giacomo
Publicado 2021

Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial

por Kumar, Anirudh, Patel, Divyang R., Brennan, Danielle M., Wolski, Kathy E., Lincoff, A. Michael, Ruotolo, Giacomo, McErlean, Ellen, Weerakkody, Govinda, Riesmeyer, Jeffrey S., Nicholls, Stephen J., Nissen, Steven E., Menon, Venu
Publicado 2019

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy

por Menon, Venu, Kumar, Anirudh, Patel, Divyang R., John, Julie St., Wolski, Kathy E., McErlean, Ellen, Riesmeyer, Jeffrey S., Weerakkody, Govinda, Ruotolo, Giacomo, Cremer, Paul C., Nicholls, Stephen J., Lincoff, A. Michael, Nissen, Steven E.
Publicado 2019

Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial

por Menon, Venu, Kumar, Anirudh, Patel, Divyang R, St John, Julie, Riesmeyer, Jeffrey, Weerakkody, Govinda, Ruotolo, Giacomo, Wolski, Kathy E, McErlean, Ellen, Cremer, Paul C, Nicholls, Stephen J, Lincoff, A Michael, Nissen, Steven E
Publicado 2020

Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies

por Taylor, Peter C, Kremer, Joel M, Emery, Paul, Zuckerman, Steven H, Ruotolo, Giacomo, Zhong, Jinglin, Chen, Lei, Witt, Sarah, Saifan, Chadi, Kurzawa, Monika, Otvos, James D, Connelly, Margery A, Macias, William L, Schlichting, Douglas E, Rooney, Terence P, de Bono, Stephanie, McInnes, Iain B
Publicado 2018